FFGTX | IGNCX | FFGTX / IGNCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 16 years | 28 years | - |
Gain YTD | 1.746 | -1.527 | -114% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | 500 | N/A | - |
Net Assets | 946M | 172M | 550% |
Annual Yield % from dividends | 1.41 | 1.58 | 89% |
Returns for 1 year | 0.62 | -3.05 | -20% |
Returns for 3 years | 14.94 | 12.59 | 119% |
Returns for 5 years | 52.62 | 22.63 | 233% |
Returns for 10 years | 55.67 | -3.31 | -1,681% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CNCR | 12.61 | 0.26 | +2.11% |
Range Cancer Therapeutics ETF | |||
TUR | 36.72 | 0.70 | +1.94% |
iShares MSCI Turkey ETF | |||
EES | 54.59 | 0.50 | +0.92% |
WisdomTree US SmallCap Earnings ETF | |||
YDEC | 22.68 | 0.08 | +0.34% |
FT Vest Intl Eq Mod Bffr ETF Dec | |||
DFAE | 25.74 | -0.10 | -0.39% |
Dimensional Emerging Core Equity Mkt ETF |